Regenerative Medicine for the Durable Remission of HIV, Plasmid Infrastructure

Grant Project Details:

Awardee:
Maria Athanasiou, PhD
Timeframe:
2021-2022
Location:
MarPam Pharma, LLC | Oakdale, MN
Amount:
$100,000
Status:
In Process
View all grants awarded

Grant timeline: proposal, updates, reports

Grant Location

MarPam Pharma, LLC
Oakdale, MN

Grant Description

We are developing a one-time treatment for durable remission of HIV in the absence of antiretroviral treatment. This treatment is a regenerative medicine therapy of autologous HIV-specific chimeric antigen receptor (CAR)-T cells that target B cell follicles, an immune protected site that permits viral replication.
Here, we propose to develop the infrastructure to produce GMP-ready plasmids, which will be used as starting materials for GMP manufacture of gammaretrovirus and CAR-T cells for the IND-enabling primate study and for the Phase 1 clinical trial.